Achieve Life Sciences, Inc. - SIC # 2830 -

Ticker Exchange SIC # Website Latest Ticker
ACHV Nasdaq 2830 www.achievelifesciences.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Achieve Life Sciences, Inc.

Sector Update: Health Care Stocks Retreat Late Afternoon - Jun 27th, 2025 1:57 pm
Top Midday Decliners - Jun 27th, 2025 12:19 pm
Traders Digest Fed's Preferred Inflation Gauge as US Equity Futures Gain Pre-Bell - Jun 27th, 2025 7:02 am
Achieve Life Sciences Announces Pricing of $45.0 Million Underwritten Public Offering - Jun 26th, 2025 9:43 pm
Achieve Life Sciences Announces Proposed Underwritten Public Offering - Jun 26th, 2025 2:03 pm
Achieve Life Sciences Announces Partnership with Omnicom to Execute Integrated, Data-Driven Launch of the First Potential New Treatment for Nicotine Dependence in Nearly Two Decades - Jun 26th, 2025 2:02 pm
Achieve Life Sciences Announces Submission of NDA to FDA for Cytisinicline as a Treatment of Nicotine Dependence for Smoking Cessation - Jun 26th, 2025 2:01 pm
Owning 46% shares,institutional owners seem interested in Achieve Life Sciences, Inc. (NASDAQ:ACHV), - Jun 12th, 2025 8:46 am
Achieve Life Sciences to Present at the Jefferies Global Healthcare Conference - May 28th, 2025 6:30 am
Achieve Life Sciences to Present New Data at the 2025 ATS International Conference Demonstrating that Cytisinicline Reduced Cravings and Nicotine Intake - May 20th, 2025 6:30 am
ACHV: Kicking Butts to Achieve June NDA Filing - May 14th, 2025 3:21 am
Achieve Life Sciences Inc (ACHV) Q1 2025 Earnings Call Highlights: Strategic Advances Amid ... - May 14th, 2025 1:06 am
Achieve Life Sciences Reports First Quarter 2025 Financial Results and Highlights Updates in Cytisinicline Program - May 13th, 2025 5:30 am
Achieve Life Sciences to Announce First Quarter 2025 Financial Results and Host Conference Call and Webcast on May 13, 2025 - May 6th, 2025 6:30 am
Achieve Life Sciences announces publication of results from Phase 3 ORCA-3 trial - Apr 22nd, 2025 9:26 am
Achieve Life Sciences Expects to File New Drug Application in US for Smoking Cessation Medication - Apr 21st, 2025 11:08 am
Achieve Life Sciences Announces Cytisinicline Phase 3 ORCA-3 Trial Publication on Smoking Cessation in JAMA Internal Medicine - Apr 21st, 2025 9:19 am
Achieve Life Sciences, Inc. (ACHV): A Bull Case Theory - Mar 20th, 2025 4:25 pm
ACHV: 2Q:25 NDA Submission - Mar 12th, 2025 3:45 am
Achieve Life Sciences Inc (ACHV) Q4 2024 Earnings Call Highlights: Strategic Advances Amid ... - Mar 12th, 2025 1:02 am